How should influenza A be managed and documented in a clinical chart?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Influenza A Clinical Charting

Document influenza A with specific vital signs, symptom onset timing, risk stratification, and treatment decisions including antiviral eligibility and antibiotic indications based on severity and complications.

Essential Documentation Elements

Initial Assessment Parameters

Chart the following vital signs at least twice daily (more frequently if severe) 1:

  • Temperature (fever defined as >38°C in adults, >38.5°C in children)
  • Respiratory rate (≥30/min indicates severity)
  • Heart rate (>100/min suggests instability)
  • Blood pressure (SBP <90 or DBP ≤60 mmHg indicates severity)
  • Oxygen saturation (target >92%, or pO2 >8 kPa)
  • Mental status (confusion scores 1 point on CURB-65)
  • Inspired oxygen concentration (FiO2)

Critical Timing Documentation

Document symptom onset time precisely - this determines antiviral eligibility. Treatment with oseltamivir is only indicated if the patient presents within 48 hours of symptom onset 1, 2.

Risk Stratification Documentation

Chart whether the patient has high-risk features 1:

  • Chronic respiratory disease (asthma on inhaled steroids, COPD, cystic fibrosis)
  • Chronic heart disease (heart failure, ischemic heart disease requiring medication)
  • Chronic renal disease (nephrotic syndrome, renal failure, transplant)
  • Chronic liver disease (cirrhosis, inflammatory bowel disease)
  • Diabetes requiring insulin or oral hypoglycemics
  • Immunosuppression (HIV, malignancy, chemotherapy, steroids >20mg prednisolone daily for >1 month)
  • Pregnancy
  • Age ≥65 years
  • Long-term care facility resident

Severity Assessment and Documentation

CURB-65 Score Calculation

Document each component 1:

  • Confusion (present/absent)
  • Urea >7 mmol/L
  • Respiratory rate ≥30/min
  • Blood pressure (SBP <90 or DBP ≤60)
  • Age ≥65 years

Score interpretation:

  • 0-2: Non-severe pneumonia
  • 3-5: Severe pneumonia requiring aggressive management

Pneumonia Classification

Document whether pneumonia is present and its pattern:

  • No pneumonia: Uncomplicated influenza or bronchitis
  • Non-severe pneumonia: CURB-65 score 0-2
  • Severe pneumonia: CURB-65 score 3-5 OR bilateral chest radiograph changes (primary viral pneumonia)

Treatment Documentation

Antiviral Therapy

Document oseltamivir administration if ALL criteria met 1, 2:

  1. Acute influenza-like illness present
  2. Fever >38°C (adults) or >38.5°C (children)
  3. Symptomatic for ≤48 hours

Dosing to chart:

  • Adults: 75 mg every 12 hours for 5 days
  • Reduce to 75 mg once daily if creatinine clearance <30 mL/min
  • Children dosing by weight 1:
    • <15 kg: 30 mg every 12 hours
    • 15-23 kg: 45 mg every 12 hours
    • ≥24 kg: 75 mg every 12 hours

Exceptions to document (may treat despite lack of fever or >48 hours) 1:

  • Immunocompromised patients
  • Very elderly unable to mount febrile response
  • Severely ill hospitalized patients
  • Severely ill children <1 year (note: off-label use)

Antibiotic Therapy Documentation

Chart antibiotic decisions algorithmically 1:

No Pneumonia Present:

  • Previously well patients: No antibiotics routinely 1, 2
  • Worsening symptoms (recrudescent fever, increasing dyspnea): Consider antibiotics
  • High-risk patients with lower respiratory features: Strongly consider antibiotics

Non-Severe Pneumonia (CURB-65 0-2):

  • First-line oral: Co-amoxiclav OR tetracycline (doxycycline)
  • Penicillin allergy: Clarithromycin or fluoroquinolone (levofloxacin/moxifloxacin)
  • Administer within 4 hours of admission 1

Severe Pneumonia (CURB-65 3-5 or bilateral infiltrates):

  • Immediate IV combination: Co-amoxiclav (or cefuroxime/cefotaxime) PLUS clarithromycin/erythromycin
  • Alternative: Fluoroquinolone with anti-pneumococcal and anti-staphylococcal activity

Supportive Care Documentation

Chart the following interventions 1:

  • Oxygen therapy: Maintain pO2 >8 kPa or SaO2 >92%
  • IV fluids: Document volume status assessment and replacement
  • Nutritional support: In severe or prolonged illness
  • Cardiac assessment: Screen for complications
  • Non-invasive ventilation: Consider in respiratory failure when ICU beds limited (requires experienced unit)

Discharge Criteria Documentation

Review 24 hours before discharge - patient should have <2 of these unstable factors 1, 2:

  1. Temperature >37.8°C
  2. Heart rate >100/min
  3. Respiratory rate >24/min
  4. Systolic BP <90 mmHg
  5. Oxygen saturation <90%
  6. Inability to maintain oral intake
  7. Abnormal mental status

Follow-Up Documentation

Chart discharge plan including 1:

  • Follow-up arrangements with GP or hospital clinic for patients with significant complications or worsening comorbidities
  • Patient education about illness, medications, and follow-up
  • Communication with GP regarding hospital course and ongoing management needs

Pediatric-Specific Documentation

For children, additionally document 1:

Indicators for HDU/ICU transfer:

  • SaO2 <92% despite FiO2 >0.6
  • Shock
  • PaCO2 >6.5 kPa with severe respiratory distress
  • Rising respiratory/pulse rate with severe distress
  • Recurrent apnea or irregular breathing
  • Encephalopathy

Antibiotic dosing by age (if indicated) 1:

  • Co-amoxiclav: 1-12 months (2.5 mL/kg of 125/31 suspension TDS), 1-6 years (5 mL TDS), 7-12 years (5 mL of 250/62 TDS)
  • Clarithromycin: Weight-based from 7.5 mg/kg BD to 250 mg BD

Common Pitfalls to Avoid

  • Do not delay antiviral treatment waiting for test results if patient presents within 48 hours with typical features
  • Do not give antibiotics routinely to previously well patients without pneumonia
  • Do not discharge patients with ≥2 unstable vital sign criteria
  • Do not forget renal dose adjustment for oseltamivir (50% reduction if CrCl <30)
  • Do not overlook high-risk patients who may benefit from antibiotics even without confirmed pneumonia

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.